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Abstract
Background: The apparent interactions between the mechanisms of action of non-steroidal anti-
inflammatory drugs (NSAIDS) and steroids suggest that co-therapy may provide beneficial
inflammatory and pain relief in the absence of side effects. The aim of the study was to compare
the effect of co-administered dexamethasone and diclofenac potassium (diclofenac K) with
diclofenac K alone on the postoperative pain, swelling and trismus after surgical removal of third
molars.
Patients and Methods: A prospective randomized double-blind study was conducted at the
Department of Oral and Maxillofacial Surgery, Lagos University Teaching Hospital, Nigeria. A total
of 100 patients were randomly allocated to two treatment groups of dexamethasone (prophylactic
8 mg and postoperative 4 mg IV) and diclofenac K (50 mg Oral before and after surgery), and
diclofenac K alone (as with first group). The overall analgesic efficacy of the drug combinations was
assessed postoperatively by determination of pain intensity using a category rating scale. Facial
swelling was measured using a tape measure placed from tragus to gonion to tragus, while
interincisal mouth-opening of patients was measured using a vernier calibrated caliper pre-
operatively and post-operatively.
Results:  Co-administration of dexamethasone and diclofenac K was significantly superior to
diclofenac alone for the relief of pain (P < 0.05), and facial swelling up to post-operative 48 hour (P
< 0.05). However, there was no significant difference for trismus relief between the two medication
protocols (P > 0.05).
Conclusion:  This study illustrates enhanced effects of co-administered dexamethasone and
diclofenac K on short-term post-operative pain and swelling, compared to diclofenac potassium
alone in third molar surgery.
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Introduction
Surgical removal of wisdom teeth under local anaesthesia
is widely carried out in general dental practice and in
many institutional surgery clinics, occupying an apprecia-
ble amount of clinical time [1,2]. This procedure is usually
associated with postoperative pain, swelling, and trismus
[1-4] as direct and immediate consequences of the surgi-
cal procedure [5,6]. The adverse effects of the wisdom
tooth surgery on the quality of life has been reported to
show a three-fold increase in patients who experience
pain, swelling and trismus alone or in combinations;
compared to those who were asymptomatic [5-7]. Many
clinicians have, thus, emphasized the necessity for better
pain, swelling and trismus control in patients who
undergo third molar surgery [8,9].
The introduction of non-steroidal anti-inflammatory
drugs (NSAIDs, e.g. diclofenac potassium and ibuprofen)
has significantly altered the management of postoperative
pain in dentistry and medicine. There are 2 possible
mechanisms for the efficacy of NSAIDs when adminis-
tered prior to surgical trauma. The first may simply be a
pharmacokinetic advantage. By administering the NSAIDs
prior to pain onset, drug absorption would have begun
and therapeutic blood level will be present at the time of
pain onset. Second, the presence of a cyclooxygenase
inhibitor at the surgical site may limit the production of
prostaglandins and prostacyclins associated with hyperal-
gesia and edema [10,11]. The use of corticosteroids (e.g.
dexamethasone, betamethasone) is another preventive
strategy for limiting postoperative edema and trismus fol-
lowing third molar extractions. Postoperative swelling
and edema may be due in part to the conversion of phos-
pholipids to arachidonic acid by phospholipase A2, and
the resultant production of leukotrienes, prostacyclins,
prostaglandins and thromboxane A2, acting as mediators
of the inflammatory response. The use of steroids may
inhibit the initial step in this process [12]. Clinical trials
in oral surgery have also supported the hypothesis that
preemptive NSAIDs and corticosteroids are effective in
delaying and preventing many postoperative sequelae
[10]. The apparent interactions between the mechanisms
of action of non-steroidal anti-inflammatory drugs
(NSAIDS) and steroids suggests that co-therapy may pro-
vide beneficial inflammatory and pain relief in the
absence of side effects.
The aim of the study was, thus, to compare the effect of co-
administered dexamethasone-diclofenac potassium with
diclofenac potassium alone, on the postoperative man-
agement of pain, swelling and trismus following removal
of impacted lower third molars.
Patients and methods
Patients who attended the Oral and Maxillofacial surgery
clinic of the Lagos University Teaching Hospital, requiring
surgical removal of unilateral or bilateral (at least 15 days
between the two surgical procedures), impacted mandib-
ular third molar teeth under local anaesthesia were
included. The study protocol and the informed consent
forms were approved by the research and ethics commit-
tee of the hospital. The study protocol was explained to
the patients in detail after which consent was obtained.
Patients were randomly allocated into two groups in a
double-blind fashion by using prepared randomizations
in sealed envelopes. Criteria for exclusion of patients
included: renal or hepatic disease, blood dyscrasia, previ-
ous or present gastric ulcers, heart disease, known hyper-
sensitivities, allergies, or idiosyncratic reactions to any
study medications, pregnancy and lactation. In addition,
patients who had taken analgesics or anti-inflammatory
drugs within 24 hours before surgery were excluded from
the study. All selected candidates were free of pain and
other inflammatory symptoms that included swelling,
hyperemia and decreased mouth opening at the time of
surgery.
In Group I, patients were given a combination dexameth-
asone and diclofenac potassium (diclofenac K). Group II
comprised of patients who were given diclofenac K alone.
The degree of surgical difficulty was assessed using Win-
ter's and Terence Ward lines and Pell-Gregory criteria [13].
Oral perioperative antibiotics (500 mg ampicillin-cloxa-
cillin, SmithKline Beecham, England and 400 mg metro-
nidazole, Aventis Pharm. Int., Switzerland) were
administered to all patients 30 minutes before surgery.
Operative procedure
Surgical extraction of the third molars was carried with
buccal guttering technique after adequate elevation and
reflection of buccal mucoperiosteal flap under local
anaesthesia (2% lignocaine hydrochloride with
1:100,000 adrenaline). Tooth delivery was followed by
meticulous irrigation of the surgical site with physiologic
saline (0.9%). The three-sided mucoperiosteal flap was
repositioned and sutured. A single operator performed all
surgical procedures.
Pain measurement
Preoperative pain was assessed using a four-point Cate-
gory Rating Scale [14,15] Accordingly, pain was recorded
as: "0-no pain" (patient experiences no discomfort), "1-
mild pain" (almost unnoticeable pain), "2-moderate
pain" (noticeable pain, but patient can still engage in rou-
tine daily activities), and "3-severe pain" (very noticeable
pain which disturbs the patient's daily routine). For each
patient, the appropriate score was recorded in the ques-Head & Face Medicine 2005, 1:11 http://www.head-face-med.com/content/1/1/11
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tionnaire by one operator at 48 h and by the patient on a
daily basis for 5 days. Before leaving the clinic, the opera-
tor ensured that all patients were thoroughly instructed
how to complete the pain self-assessment diary and when
to take medications.
Measurement of facial width
As no published method satisfies all criteria for assessing
facial swelling, we decided to use a measuring tape to
measure facial width and swelling in one-dimension only.
Facial width (swelling) was measured using a measuring
tape. The reference points used were the tip of tragus of
left and right ears, with the gonium in between. A single
operator, repeating the procedure three times on each
patient, made the measurements. The average of measure-
ments was then taken (in cm) and recorded. The measure-
ments were carried out just before the surgery and at post-
operative days 1, 2, and 7. Postoperative swelling was
expressed as a percentage increase in facial width.
Measurement of mouth-opening ability
A vernier-calibrated sliding caliper was used to measure
maximum interincisal mouth-opening ability of the
patient at the commencement of the procedure. The refer-
ence point used was incisal edge of the maxillary central
incisor and incisal edge of mandibular central incisor at
maximum opening available.
The measurements were made in triplicate and the aver-
age was recorded in millimetres (mm). The measurement
was carried out just before the surgery and at post-opera-
tive days 1, 2, and 7. Postoperative trismus was measured
as a percentage decrease in mouth opening.
Medication
The operator supplied the medications to ensure compli-
ance. Dexamethasone (Epil Pharmaceuticals, China) was
given parenterally 8 mg 30 minutes preoperatively, and
then 4 mg 6 hours postoperatively in two doses.
Diclofenac K (Novartis, Switzerland) was given 50 mg, 30
minutes preoperatively; and thereafter 50 mg, 2 times
daily for five days. All patients were placed on a five-day
antibiotic regimen (500 mg Ampicillin-cloxacillin, Smith-
Kline Beecham, England; 4 times daily and 400 mg Met-
ronidazole, Aventis Switzerland, 3 times daily). All the
medications were administered orally, except dexametha-
sone, which was administered parenterally.
Statistical Analysis
Data was analyzed using SPSS for windows (v11.5, SPSS
Inc, Chicago, IL) statistical software package. One-way
analysis of variance, student's t-test and χ2 were used for
repeated measures for category rating scale, interincisal
opening and facial swelling. The level of significance was
set at P < 0.05.
Results
A total of 100 patients (equally distributed into groups I
and II) who completed the study were included in the
analysis. The mean age of the participants was 27.9 ± 5.2
years (range, 19–45 years; group I: 29.8 ± 5.3 years and
group II: 26.1 ± 4.5 years). The male-to-female ratio was
1:1.1. The radiographic analysis of the type of impactions
showed that mesio-angular impaction constituted 51.0%
of cases, followed by disto-angular impaction (21.0%,
Table 1).
Table 2 presents postoperative pain intensity, facial swell-
ing and maximal mouth opening on post-operative days
1 and 2. For group I, the mean pain score on days 1 and 2
was significantly lower than that for group II (p < .05,
Table 2). Co-administration of Dexamethasone-
diclofenac K led to a significant reduction in both postop-
erative pain and swelling on Days 1 and 2 when compared
with diclofenac K alone (P < 0.05).
Although there was no significant difference between the
treatment groups with regard to reduction in mouth open-
ing, the "trismus" scores of group I (0.31 mm) were lower
than those of group II (3.19 mm) between 24 h and 48 h.
By the post-operative 7th day, all symptoms had restored
to the preoperative level in both groups. Neither groups
demonstrated any adverse reaction, side effect or other
complications (e.g., tendency for bleeding) during the fol-
low-up period.
Discussion
By pharmacologically controlling the extent of the inflam-
matory process, the intensity or severity of postoperative
sequelae such as pain, swelling and trismus, may be
reduced [16,17]. One technique that has been proposed
for reduction of postoperative inflammation is the admin-
istration of corticosteroids [16]. Cortisol and the synthetic
analogue of cortisol have the capacity to interfere with the
physiologic processes of inflammation and, thus, sup-
press the development of local fever, redness, swelling
and tenderness by which inflammation is recognized
[16]. Another technique is to control the synthesis of pros-
taglandins. Prostaglandins play a major role in the induc-
Table 1: Types of impactions
Types Frequency (%)
Mesioangular 51 (51.0)
Distoangular 21 (21.0)
Horizontal 16(16.0)
Vertical 12(12.0)
Total 100 (100)Head & Face Medicine 2005, 1:11 http://www.head-face-med.com/content/1/1/11
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tion of pain, inflammation, and fever [3,11]. The
reduction of biosynthesis of prostaglandins by inhibition
of the cyclo-oxygenase enzyme system is considered an
important mechanism of action of NSAIDs. When admin-
istered preoperatively, NSAIDs have been shown to be
particularly effective in combating postoperative pain
[3,11].
Preventive strategies for postoperative management of
pain and inflammation are based on the known ability of
NSAIDs to block the arachidonic acid cascade. When
NSAIDs are administered preoperatively, absorption and
distribution of the medication may occur before the initi-
ation of tissue trauma, the ensuing synthesis of prostag-
landins and the subsequent inflammatory response.
Prevention of the inflammatory response may decrease
the sequelae of tissue trauma; especially the accompany-
ing pain [11]. Diclofenac K has been shown to be useful
in controlling postoperative pain after removal of third
molars [18]. Diclofenac K is known to possess both anal-
gesic and anti-inflammatory effect. Due to its anti-inflam-
matory effects [18], the administration of dexamethasone
may synergize the anti-inflammatory effect of cataflam
and contribute to the reduction of inflammatory exudates
as well as edema and pain. Therefore the co-administra-
tion of diclofenac K and dexamethasone may be expected
to reduce post-operative pain more than that achieved
with diclofenac K alone [18].
The present study assessed the clinical effect dexametha-
sone-diclofenac K combination and diclofenac K alone on
pain, facial swelling and trismus. Regardless of the drug
combination used, the pattern of postoperative pain has
been reported to increase between the post-operative days
1 and 3, after which the symptoms subside gradually
within one week [19-22]. Our results confirm this obser-
vation. The comparison of pain intensity between the dex-
amethasone-diclofenac K group and diclofenac K group
showed significant difference between the two groups (P
< 0.05), indicating an enhanced analgesic effect of
diclofenac K when administered in combination with
dexamethasone. This finding corroborates with those of
previous reports [3,23-26]. Schultze-Mosgau et al [25]
investigated the combined use of ibuprofen and methyl-
prednisolone for pain relief, concluding that this combi-
nation has good analgesic and anti-inflammatory action.
It has also been reported that a single dose administration
of a glucocorticoid reduces tissue levels of bradykinin and
suppresses circulating levels of cortisol and beta-endor-
phin [25]. As known, bradykinin and kallidin are the two
kinins that act independently as well as synergistically
with products of the arachidonic acid cascade to produce
both hyperalgesia as well as increased vascular permeabil-
ity [26].
Post-surgical facial edema is difficult to quantify accu-
rately, since it requires a three-dimensional measurement
with an irregular, convex surface and can manifest itself
internally as well as externally. Over the years, numerous
researchers have tried various techniques in an effort to
objectively measure edema [23,26], most of which are
indirect assessments of the altered contours of skin sur-
face. Measurement tools mentioned in the literature have
included visual analog scales, trismus recordings, stand-
ardized stereo-radiographic or photographic measure-
ments, computerized tomography, modified face bow
devices, ultrasonography, facial plethysmographs, or vari-
ous other means of taking direct facial measurements
[23,26]. In the present study, a single measurement from
the tip of tragus to gonion to the tip of contralateral tragus
was taken. The recordings were made in triplicate and the
average was recorded. It is noteworthy to mention herein
that the cheek swelling following third molar surgery is
diffuse in different planes and is very difficult to measure
accurately. The co-administration of dexamethasone
diclofenac K preoperatively and postoperatively, pro-
duced a clear reduction in postoperative pain and cheek
swelling. The mean increase in facial swelling in days 1
and 2 in Group I (dexamethasone- diclofenac K combina-
tion) was significantly less than that of Group II
(diclofenac K only). This result shows that co-administra-
tion of dexamethasone diclofenac K also enhances the
control of postoperative facial swelling [24,27-29].
Independent T-test did not show any significant differ-
ence in reduction of mouth opening (trismus) between
the study groups (P > 0.05). While this observation does
not corroborate with those of previous reports [21,22,25],
the enhanced effect of steroids on mouth-opening may be
observed clinically. In the present study, the mean reduc-
Table 2: Pain intensity, facial swelling and mouth opening at Days 1 and 2 (D1, D2) in group I (Dexamethasone-diclofecac K) and group 
II (Diclofenac only). Values are expressed as mean ± SD
Group N Pain intensity Facial Swelling Mouth Opening
D1 D2 D1 D2 D1 D2
Group I 50 0.62 ± 0.6* 0.5 ± 0.51* 30.9 ± 1.6* 31.0 ± 1.58* 36.0 ± 11.2 38.1 ± 10.05
Group II 50 1.64 ± 0.9* 1.3 ± 0.62* 31.7 ± 1.6* 32.04 ± 1.5* 39.2 ± 11.3 36.0 ± 10.02
*p < 0.05Head & Face Medicine 2005, 1:11 http://www.head-face-med.com/content/1/1/11
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tion in mouth-opening between the post-operative days 1
and 2 were 0.31 mm and 3.19 mm, for groups I (dexame-
thasone and diclofenac K) and II (diclofenac K only),
respectively. This shows a "clinically significant" differ-
ence in the interincisal distance. These results indicate a
positive clinical association between the adjunct use of
dexamethasone and postoperative recovery of trismus in
third molar surgery.
The time course for pain and facial swelling findings
described in the present study are in agreement with those
of a recent multicenter trial indicating similar symptoms
that reached a maximum at Days 1 or 2 postoperatively
and generally resolved at Day 7 [30,31].
The potency and dosage of dexamethasone within the first
24 h (total of 16 mg, including pre-operative dose) was
adequate to enhance the efficacy of diclofenac K. It
appears that steroids are preferably administered pre-
operatively, extending the coverage up to 24–48 hours
after surgery. Intravenous administration of dexametha-
sone, as done in the present study, enhances earlier bioa-
vailability in comparison to oral administration [9]. Such
treatment with high dosage does not impair adrenal func-
tion. Additionally, intravenous administration of dexam-
ethasone prior to third molar surgery bears no detrimental
impact on wound healing, even in patients predicted to be
at high risk for delayed clinical recovery [9].
Conclusion
This study illustrates enhanced effects of co-administered
dexamethasone and diclofenac K on short-term post-
operative pain and swelling, compared to diclofenac
potassium alone in third molar surgery.
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